The quantitative level of T315I mutated BCR-ABL predicts for major molecular response to second-line nilotinib or dasatinib treatment in patients with chronic myeloid leukemia
| Image |  |
|---|---|
| Description | scientific article published on 12 October 2012 |
| Author/s |
author: Dietger Niederwieser Andreas Hochhaus |
| Publication date | October 12, 2012 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |